A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol describes a BRET-based assay for measuring the interactions of the CRAF kinase with 14-3-3 proteins in live cells. The protocol outlines steps for preparing the cells, reading BRET emissions, and data analysis. An example result with identification of appropriate controls and troubleshooting for assay optimization is also presented.
CRAF is a primary effector of RAS GTPases and plays a critical role in the tumorigenesis of several KRAS-driven cancers. In addition, CRAF is a hotspot for germline mutations, which are shown to cause the developmental RASopathy, Noonan syndrome. All RAF kinases contain multiple phosphorylation-dependent binding sites for 14-3-3 regulatory proteins. The differential binding of 14-3-3 to these sites plays essential roles in the formation of active RAF dimers at the plasma membrane under signaling conditions and in maintaining RAF autoinhibition under quiescent conditions. Understanding how these interactions are regulated and how they can be modulated is critical for identifying new therapeutic approaches that target RAF function. Here, I describe a bioluminescence resonance energy transfer (BRET)-based assay for measuring the interactions of CRAF with 14-3-3 proteins in live cells. Specifically, this assay measures the interactions of CRAF fused to a Nano luciferase donor and 14-3-3 fused to a Halo tag acceptor, where the interaction of RAF and 14-3-3 results in donor-to-acceptor energy transfer and the generation of the BRET signal. The protocol further shows that this signal can be disrupted by mutations shown to prevent 14-3-3 binding to each of its high-affinity RAF docking sites. This protocol describes the procedures for seeding, transfecting, and replating the cells, along with detailed instructions for reading BRET emissions, performing data analysis, and confirming protein expression levels. In addition, example assay results, along with optimization and troubleshooting steps, are provided.
RAF kinases (ARAF, BRAF, and CRAF) are the direct effectors of RAS GTPases and the initiating members of the pro-proliferative/pro-survival RAF-MEK-ERK kinase cascade. Recent studies have shown that CRAF expression plays a key role in the tumorigenesis of several KRAS-driven cancers, including non-small cell lung cancer and pancreatic ductal adenocarcinoma1,2,3,4,5. Moreover, germline CRAF mutations cause a particularly severe form of the RASopathy, Noonan syndrome6,
NOTE: This assay is performed in 293FT cells. A well characterized and readily transfectable epithelial line derived from human embryonic kidney cells. A single confluent 10 cm culture dish of these cells typically provides enough cells for seeding 20 wells of 6-well tissue culture plates. Steps 1-3 must be performed using sterile technique in a biological safety cabinet.
1. Cell seeding (Day 1)
NOTE: In this step, the cells are detached from the tiss.......
When performed as described in this protocol (Figure 2), the interaction of Nano-CRAFWT and 14-3-3ζ-Halo should produce corrected BRET ratios of 50-60 mBU (Figure 3A; Supplementary Table 1). CRAF contains two phosphorylation-dependent 14-3-3 docking sites, the N' site and the C' site (Figure 1)8. Therefore, appropriate controls for reducing CRAF:14-3-3ζ binding in.......
Previous studies have shown that 14-3-3 proteins play critical roles in both the activation and inhibition of RAF kinases. Understanding how these binding events are regulated and the effects of modulating these interactions on RAF signaling and RAF-driven oncogenesis may uncover new therapeutic vulnerabilities that target CRAF function. However, the Raf activation cycle is supported by a plethora of associated proteins, post translational modifications, and changes in subcellular localization8, a.......
This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under project number ZIA BC 010329.
....Name | Company | Catalog Number | Comments |
Antibodies | |||
HaloTag® mouse monoclonal antibody | Promega | G9211 | Antibody for detecting HaloTag tagged proteins by immunoblot |
NanoLuc® mouse monoclonal antibody | R&D Systems | MAB10026 | Antibody for detecting Nano-tagged proteins by immunoblot |
CRAF mouse monoclonal antibody (E10)Â | Santa Crus Biotechnology | sc-7267 | Antibody directly detecting CRAF proteins by immunoblot |
ECL anti-mouse HRP secondary antibody | Amersham | NA931-1MLÂ | Secondary HRP conjugated mouse antibody (from sheep) |
Reagents | |||
X-tremeGENEâ„¢ 9 | Roche/Sigma | 6365809001 | |
NanoBRET™ kit | Promega | N1661 | NanoBRET kit containing Halo 618 ligand and NanoGlo (nanoluciferase) substrate |
DPBS, without Ca++ and Mg++ | Quality Biologicals | 114-057-101 | |
Trypsin-EDTA (0.05%), phenol red | Life Technologies | 25300120 | |
DMEM cell culture media | Life Technologies | 11995073 | High glucose, L-glutamine, phenol red, sodium pyruvate; without HEPES, suppliment media with 10% FBS, 2 mM L-glutamine and 100U penicillin-streptomycin |
L-Glutamine (200 mM)Â Â | Life Technologies | 25030164 | |
Penicillin-Streptomycin (10,000 U/mL) | Life Technologies  | 15140163 | |
Opti-MEM™ I reduced serum media | Gibco | 31985062 | For cell transfection |
Opti-MEM reduced serum media, no phenol red | Gibco | 11058021 | For replating cells on Day 3. Supplement with 2 mM L-glutamine and 100U penicillin-streptomycin, along with 10% FBS (where indicated). |
Invitrogen Trypan Blue Stain | Thermo Scientific | T10282 | |
NP40 lysis buffer | N/A | N/A | 20 mM Tris (pH 8.0), 137mM NaCl, 10% glycerol, NP40 alternative (Milipore, Cat# 492016). Store at 4 degrees C.. Add the following protease and phosphatase immediately prior to use: 20 µM leupeptin, 0.5 mM sodium orthovanidate, 0.15 U/mL, 1mM PMSF. |
5x gel sample buffer | N/A | N/A | 240 mM Tris (pH 8.0), 9.5% SDS, 30% glycerol, 500mM DTT, 3mM bromophenol blue. Store at -20 degrees C. |
Cell lines | |||
293FT cells (human) | Thermo Scientific | R70007 | |
DNA vectors | |||
pCMV5-Nano-CRAF WT and mutant | N/A | N/A | |
pCMV5-14-3-3ζ-Halo  | N/A | N/A | |
Equipment | |||
EnVision 2104 Multimode Plate Reader | PerkinElmer 2104 | 2104-0010 | 600LP NanoBRET & M460/50 nm NanoBRET emmisions filters, Luminescence 404 mirror, 6.5 mm measurement height and 0.1 s measurement time |
Invitrogen Countess™ II Automated Cell Counter | Thermo Scientific | AMQAX1000 | |
ThermoFisher E1-ClipTip™ Multichannel Pipettor | Thermo Scientific  | 4672070 | |
Software | |||
GraphPad Prism (version 10.0.3) | GraphPad | www.graphpad.com | |
Other | |||
ThermoFisher ClipTip Multichannel pipette tips | Thermo Scientific | 94410153 | |
Reagent Reservoir, 25 mL Divided, Sterile | Thomas Scientific | 1228K16 | |
Perkin Elmer 384-well CulturPlate™ | PerkinElmer | 6007680 | White, polystyrene, tissue culture treated |
Countess Cell Counting Chamber Slides | Thermo Scientific | C10228 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved